World
2022.06.08 07:09 GMT+8

U.S. FDA advisers back Novavax COVID-19 vaccine

Updated 2022.06.08 07:09 GMT+8
CGTN

Advisers to the U.S. Food and Drug Administration (FDA) on Tuesday recommended that the agency authorize Novavax's two dose vaccine against COVID-19 in a 21-0 vote.

Copyright © 

RELATED STORIES